Echo Street Capital Management’s AbbVie ABBV Stock Holding History

Echo Street Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,732	Closed	-$1.18M	–	453
2023 Q2	$1.18M	Buy	8,732 +6,245	+251%	+$916K	0.01%	125
2023 Q1	$396K	Buy	+2,487	New	+$380K	﹤0.01%	316
2021 Q3	–	Sell	-10,778	Closed	-$1.21M	–	618
2021 Q2	$1.21M	Buy	10,778 +7,719	+252%	+$869K	0.01%	178
2021 Q1	$331K	Buy	+3,059	New	+$327K	﹤0.01%	403

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Echo Street Capital Management's ABBV Position: Q3 2023 in Review

Echo Street Capital Management sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 8,732 shares — an estimated $1.18M sold.

Echo Street Capital Management first reported a position in ABBV in Q1 2021 and held it in 4 quarters. The position peaked at $1.21M in Q2 2021. 3,109 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

Echo Street Capital Management reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
Echo Street Capital Management sold 8,732 AbbVie shares in Q3 2023, an estimated $1.18M.
Echo Street Capital Management first reported a position in AbbVie in Q1 2021 and held it in 4 quarters.
Echo Street Capital Management's AbbVie position peaked at $1.21M in Q2 2021.
3,109 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Echo Street Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.